Physicians' Clinic of Iowa PC

Summary

Physicians' Clinic of Iowa PC is a medical facility located in Cedar Rapids, Iowa. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Physicians' Clinic of Iowa PC is involved with conducting 72 clinical trials across 109 conditions. There are 2 research doctors associated with this hospital, such as William P. Fusselman and Bharat Jenigiri.

Top PIs

Clinical Trials running at Physicians' Clinic of Iowa PC

Lung Cancer

Breast Cancer

Colorectal Cancer

Ovarian Cancer

Cancer

Breast cancer

Non-Small Cell Lung Cancer

Multiple Myeloma

Melanoma

Small Cell Lung Cancer

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

BNT327 + Chemotherapy

for Non-Small Cell Lung Cancer

This is a Phase 2/3, multisite, randomized, open-label study in participants with first-line non-small cell lung cancer (NSCLC). This study includes two substudies (substudy A and substudy B) that will recruit participants according to histological subtypes due to differences in chemotherapy choice for standard-of-care and type of NSCLC.

Recruiting

1 award

Phase 2 & 3

2 criteria

Cannabis Use

for Breast Cancer

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

Recruiting

1 award

N/A

10 criteria